Toll-like receptor-mediated recognition of herpes simplex virus

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 2, 2010, Pages 718-729

  Martinez Martin, Nadia ^a   Viejo Borbolla, Abel ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Chemokine; Cytokine; Herpes Virus; HSV; Immune Response; Review; Toll like receptor

Indexed keywords

AMINOQUINOLINE DERIVATIVE; CYTOKINE; IMIDAZOLE DERIVATIVE; IMIQUIMOD; RESIQUIMOD; TOLL LIKE RECEPTOR;

ANIMAL; DRUG EFFECT; DRUG POTENTIATION; HERPES SIMPLEX; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SIMPLEXVIRUS;

AMINOQUINOLINES; ANIMALS; CYTOKINES; HERPES SIMPLEX; HUMANS; IMIDAZOLES; MICE; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; TOLL-LIKE RECEPTORS;

EID: 77957302953     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. S. Akira, S. Uematsu and O. Takeuchi: Pathogen recognition and innate immunity. Cell 124, 783-801 (2006) (Pubitemid 43261452)
2. R. Medzhitov: Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135-145 (2001) (Pubitemid 33741967)
3. K. Takeda and S. Akira: Toll-like receptors in innate immunity. Int Immunol 17, 1-14 (2005)
4. C. Pasare and R. Medzhitov: Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21, 733-741 (2004) (Pubitemid 39487894)
5. T. Imanishi, H. Hara, S. Suzuki, N. Suzuki, S. Akira and T. Saito: Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 178, 6715-6719 (2007) (Pubitemid 46847393)
6. A. Iwasaki and R. Medzhitov: Toll-like receptor control of the adaptive immune responses. Nat Immunol 5, 987-995 (2004) (Pubitemid 41057715)
7. H. Macleod and L. M. Wetzler: T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007, pe48 (2007)
8. B. Lemaitre, E. Nicolas, L. Michaut, J. M. Reichhart and J. A. Hoffmann: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983 (1996) (Pubitemid 26336801)
9. R. Medzhitov, P. Preston-Hurlburt and C. A. Janeway, Jr.: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997) (Pubitemid 27334820)
10. A. Poltorak, X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton and B. Beutler: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998) (Pubitemid 29001265)
11. B. Beutler: Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430, 257-263 (2004) (Pubitemid 38902439)
12. G. Paz-Bailey, M. Ramaswamy, S. J. Hawkes and A. M. Geretti: Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm Infect 83, 16-22 (2007) (Pubitemid 46293800)
13. F. Xu, M. R. Sternberg, B. J. Kottiri, G. M. Mcquillan, F. K. Lee, A. J. Nahmias, S. M. Berman and L. E. Markowitz: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Jama 296, 964-973 (2006) (Pubitemid 44285373)
14. E. Freedman and A. Mindel: Epidemiology of herpes and HIV co-infection. J HIV Ther 9, 4-8 (2004)
15. P. Van De Perre, M. Segondy, V. Foulongne, A. Ouedraogo, I. Konate, J. M. Huraux, P. Mayaud and N. Nagot: Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 8, 490-497 (2008) (Pubitemid 352005823)
16. H. Oshiumi, M. Sasai, K. Shida, T. Fujita, M. Matsumoto and T. Seya: TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278, 49751-49762 (2003) (Pubitemid 37548808)
17. L. Alexopoulou, A. C. Holt, R. Medzhitov and R. A. Flavell: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738 (2001) (Pubitemid 33009951)
18. S. S. Diebold, T. Kaisho, H. Hemmi, S. Akira and C. Reis E Sousa: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529-1531 (2004) (Pubitemid 38314425)
19. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner and S. Bauer: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529 (2004) (Pubitemid 38314424)
20. A. Krug, G. D. Luker, W. Barchet, D. A. Leib, S. Akira and M. Colonna: Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103, 1433-1437 (2004) (Pubitemid 38168659)
21. J. Lund, A. Sato, S. Akira, R. Medzhitov and A. Iwasaki: Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198, 513-520 (2003) (Pubitemid 36976063)
22. K. Tabeta, P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, L. Alexopoulou, R. A. Flavell and B. Beutler: Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101, 3516-3521 (2004) (Pubitemid 38338227)
23. M. Yamamoto, S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda and S. Akira: TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4, 1144-1150 (2003) (Pubitemid 37428043)
24. K. Hoebe, X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han and B. Beutler: Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424, 743-748 (2003) (Pubitemid 37021696)
25. K. W. Boehme and T. Compton: Innate sensing of viruses by toll-like receptors. J Virol 78, 7867-7873 (2004) (Pubitemid 38944272)
26. J. M. Blander and R. Medzhitov: Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808-812 (2006)
27. G. M. Barton, J. C. Kagan and R. Medzhitov: Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7, 49-56 (2006) (Pubitemid 41823868)
28. A. Krug, A. R. French, W. Barchet, J. A. Fischer, A. Dzionek, J. T. Pingel, M. M. Orihuela, S. Akira, W. M. Yokoyama and M. Colonna: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119 (2004) (Pubitemid 38925271)
29. D. Lagos, R. J. Vart, F. Gratrix, S. J. Westrop, V. Emuss, P. P. Wong, R. Robey, N. Imami, M. Bower, F. Gotch and C. Boshoff: Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe 4, 470-483 (2008)
30. D. S. Mansur, E. G. Kroon, M. L. Nogueira, R. M. Arantes, S. C. Rodrigues, S. Akira, R. T. Gazzinelli and M. A. Campos: Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 166, 1419-1426 (2005) (Pubitemid 40586512)
31. P. P. Sarangi, B. Kim, E. Kurt-Jones and B. T. Rouse: Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 81, 11128-11138 (2007) (Pubitemid 47536085)
32. A. Bowie, E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower and L. A. O'neill: A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97, 10162-10167 (2000)
33. E. A. Kurt-Jones, L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson and R. W. Finberg: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1, 398-401 (2000)
34. J. C. Rassa, J. L. Meyers, Y. Zhang, R. Kudaravalli and S. R. Ross: Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A 99, 2281-2286 (2002) (Pubitemid 34169052)
35. K. Bieback, E. Lien, I. M. Klagge, E. Avota, J. Schneider-Schaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. Ter Meulen and S. Schneider-Schaulies: Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76, 8729-8736 (2002) (Pubitemid 34864068)
36. J. C. Rassa and S. R. Ross: Viruses and Toll-like receptors. Microbes Infect 5, 961-968 (2003) (Pubitemid 36980849)
37. J. M. Lund, L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki and R. A. Flavell: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101, 5598-5603 (2004) (Pubitemid 38481202)
38. R. W. Finberg, J. P. Wang and E. A. Kurt-Jones: Toll like receptors and viruses. Rev Med Virol 17, 35-43 (2007) (Pubitemid 46114123)
39. K. L. Mossman and A. A. Ashkar: Herpesviruses and the innate immune response. Viral Immunol 18, 267-281 (2005) (Pubitemid 41106006)
40. M. Thapa and D. J. Carr: Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection. Open Immunol J 1, 33-41 (2008)
41. T. R. Wuest and D. J. Carr: The role of chemokines during herpes simplex virus-1 infection. Front Biosci 13, 4862-4872 (2008) (Pubitemid 351599641)
42. T. Compton, E. A. Kurt-Jones, K. W. Boehme, J. Belko, E. Latz, D. T. Golenbock and R. W. Finberg: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77, 4588-4596 (2003) (Pubitemid 36402808)
43. K. W. Boehme, M. Guerrero and T. Compton: Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177, 7094-7102 (2006) (Pubitemid 44715077)
44. J. P. Wang, E. A. Kurt-Jones, O. S. Shin, M. D. Manchak, M. J. Levin and R. W. Finberg: Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 79, 12658-12666 (2005) (Pubitemid 41433185)
45. E. Gaudreault, S. Fiola, M. Olivier and J. Gosselin: Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 81, 8016-8024 (2007) (Pubitemid 47101487)
46. H. J. Martin, J. M. Lee, D. Walls and S. D. Hayward: Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol 81, 9748-9758 (2007) (Pubitemid 350067679)
47. J. West and B. Damania: Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 82, 5440-5449 (2008) (Pubitemid 351705251)
48. S. Tengvall and A. M. Harandi: Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice. J Reprod Immunol 78, 49-57 (2008) (Pubitemid 351609116)
49. S. Y. Zhang, E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, C. Picard, A. Chapgier, S. Plancoulaine, M. Titeux, C. Cognet, H. Von Bernuth, C. L. Ku, A. Casrouge, X. X. Zhang, L. Barreiro, J. Leonard, C. Hamilton, P. Lebon, B. Heron, L. Vallee, L. Quintana-Murci, A. Hovnanian, F. Rozenberg, E. Vivier, F. Geissmann, M. Tardieu, L. Abel and J. L. Casanova: TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522-1527 (2007) (Pubitemid 47417427)
50. M. Gilliet, W. Cao and Y. J. Liu: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8, 594-606 (2008)
51. J. M. Lund, M. M. Linehan, N. Iijima and A. Iwasaki: Cutting Edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection In situ. J Immunol 177, 7510-7514 (2006) (Pubitemid 44846264)
52. T. Ito, H. Kanzler, O. Duramad, W. Cao and Y. J. Liu: Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107, 2423-2431 (2006) (Pubitemid 43345563)
53. S. Karlin, W. Doerfler and L. R. Cardon: Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J Virol 68, 2889-2897 (1994) (Pubitemid 24129736)
54. H. Hochrein, B. Schlatter, M. O'keeffe, C. Wagner, F. Schmitz, M. Schiemann, S. Bauer, M. Suter and H. Wagner: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc Natl Acad Sci U S A 101, 11416-11421 (2004) (Pubitemid 39038361)
55. S. B. Rasmussen, L. N. Sorensen, L. Malmgaard, N. Ank, J. D. Baines, Z. J. Chen and S. R. Paludan: Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J Virol 81, 13315-13324 (2007) (Pubitemid 350247828)
56. L. N. Sorensen, L. S. Reinert, L. Malmgaard, C. Bartholdy, A. R. Thomsen and S. R. Paludan: TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 181, 8604-8612 (2008)
57. A. Sato, M. M. Linehan and A. Iwasaki: Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A 103, 17343-17348 (2006) (Pubitemid 44788971)
58. R. Ahmad, S. El Bassam, P. Cordeiro and J. Menezes: Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Blood 112, 2360-2368 (2008)
59. S. Daubeuf, D. Singh, Y. Tan, H. Liu, H. J. Federoff, W. J. Bowers and K. Tolba: HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113, 3264-3275 (2009)
60. C. Cermelli, C. F. Orsi, A. Ardizzoni, E. Lugli, V. Cenacchi, A. Cossarizza and E. Blasi: Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2. Microbiol Immunol 52, 575-584 (2008)
61. H. Hasannejad, R. Takahashi, M. Kimishima, K. Hayakawa and T. Shiohara: Selective impairment of Tolllike receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 120, 69-75 (2007) (Pubitemid 46990500)
62. P. Peri, R. K. Mattila, H. Kantola, E. Broberg, H. S. Karttunen, M. Waris, T. Vuorinen and V. Hukkanen: Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol J 5, 140 (2008)
63. A. Casrouge, S. Y. Zhang, C. Eidenschenk, E. Jouanguy, A. Puel, K. Yang, A. Alcais, C. Picard, N. Mahfoufi, N. Nicolas, L. Lorenzo, S. Plancoulaine, B. Senechal, F. Geissmann, K. Tabeta, K. Hoebe, X. Du, R. L. Miller, B. Heron, C. Mignot, T. B. De Villemeur, P. Lebon, O. Dulac, F. Rozenberg, B. Beutler, M. Tardieu, L. Abel and J. L. Casanova: Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308-312 (2006) (Pubitemid 44571977)
64. A. Alcami and U. H. Koszinowski: Viral mechanisms of immune evasion. Mol Med Today 6, 365-372 (2000)
65. E. A. Kurt-Jones, M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M. M. Arnold, D. M. Knipe and R. W. Finberg: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101, 1315-1320 (2004) (Pubitemid 38182686)
66. E. A. Kurt-Jones, J. Belko, C. Yu, P. E. Newburger, J. Wang, M. Chan, D. M. Knipe and R. W. Finberg: The role of toll-like receptors in herpes simplex infection in neonates. J Infect Dis 191, 746-748 (2005) (Pubitemid 40271064)
67. H. Karlsson, C. Hessle and A. Rudin: Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 70, 6688-6696 (2002) (Pubitemid 35387899)
68. R. N. Aravalli, S. Hu, T. N. Rowen, J. M. Palmquist and J. R. Lokensgard: Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175, 4189-4193 (2005) (Pubitemid 41361951)
69. J. K. Olson and S. D. Miller: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173, 3916-3924 (2004) (Pubitemid 39280755)
70. R. N. Aravalli, S. Hu and J. R. Lokensgard: Toll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia. J Neuroinflammation 4, 11 (2007)
71. P. Y. Bochud, A. S. Magaret, D. M. Koelle, A. Aderem and A. Wald: Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis 196, 505-509 (2007) (Pubitemid 47206095)
72. X. Jin, Q. Qin, W. Chen and J. Qu: Expression of tolllike receptors in the healthy and herpes simplex virus-infected cornea. Cornea 26, 847-852 (2007) (Pubitemid 47220558)
73. A. Nazli, X. D. Yao, M. Smieja, K. L. Rosenthal, A. A. Ashkar and C. Kaushic: Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women. Antiviral Res 81, 103-112 (2009)
74. P. A. Pioli, E. Amiel, T. M. Schaefer, J. E. Connolly, C. R. Wira and P. M. Guyre: Differential expression of Tolllike receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 72, 5799-5806 (2004) (Pubitemid 39303691)
75. A. A. Ashkar, S. Bauer, W. J. Mitchell, J. Vieira and K. L. Rosenthal: Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 77, 8948-8956 (2003) (Pubitemid 36936104)
76. A. A. Ashkar, X. D. Yao, N. Gill, D. Sajic, A. J. Patrick and K. L. Rosenthal: Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 190, 1841-1849 (2004) (Pubitemid 39487831)
77. N. Gill, P. M. Deacon, B. Lichty, K. L. Mossman and A. A. Ashkar: Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J Virol 80, 9943-9950 (2006) (Pubitemid 44522588)
78. A. M. Harandi, K. Eriksson and J. Holmgren: A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J Virol 77, 953-962 (2003) (Pubitemid 36055517)
79. M. M. Herbst-Kralovetz and R. B. Pyles: Quantification of poly (I: C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 80, 9988-9997 (2006) (Pubitemid 44522593)
80. D. Sajic, A. A. Ashkar, A. J. Patrick, M. J. Mccluskie, H. L. Davis, K. L. Levine, R. Holl and K. L. Rosenthal: Parameters of CpG oligodeoxynucleotide- induced protection against intravaginal HSV-2 challenge. J Med Virol 71, 561-568 (2003) (Pubitemid 37309928)
81. X. Zhang, A. A. Chentoufi, G. Dasgupta, A. B. Nesburn, M. Wu, X. Zhu, D. Carpenter, S. L. Wechsler, S. You and L. Benmohamed: A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge. Mucosal Immunol 2, 129-143 (2009)
82. K. E. Mark, L. Corey, T. C. Meng, A. S. Magaret, M. L. Huang, S. Selke, H. B. Slade, S. K. Tyring, T. Warren, S. L. Sacks, P. Leone, V. A. Bergland and A. Wald: Topical resiquimod 0.0.1% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis 195, 1324-1331 (2007) (Pubitemid 46649619)
83. R. L. Miller, T. C. Meng and M. A. Tomai: The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect 21, 69-87 (2008) (Pubitemid 351628232)
84. R. D. Weeratna, S. R. Makinen, M. J. Mccluskie and H. L. Davis: TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). Vaccine 23, 5263-5270 (2005) (Pubitemid 41443432)
85. N. Gill, E. J. Davies and A. A. Ashkar: The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection. Am J Reprod Immunol 59, 35-43 (2008) (Pubitemid 350285581)
86. N. Boivin, Y. Sergerie, S. Rivest and G. Boivin: Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis. J Infect Dis 198, 664-672 (2008)
87. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake and M. Kimoto: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189, 1777-1782 (1999) (Pubitemid 29272694)
88. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda and S. Akira: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162, 3749-3752 (1999) (Pubitemid 29314747)
89. C. Werts, R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, D. M. Underhill, C. J. Kirschning, H. Wagner, A. Aderem, P. S. Tobias and R. J. Ulevitch: Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2, 346-352 (2001) (Pubitemid 33706346)
90. M. Gilleron, V. F. Quesniaux and G. Puzo: Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 278, 29880-29889 (2003) (Pubitemid 36962376)
91. M. G. Netea, C. Van Der Graaf, J. W. Van Der Meer and B. J. Kullberg: Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 23, 672-676 (2004) (Pubitemid 39304320)
92. R. T. Gazzinelli, C. Ropert and M. A. Campos: Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev 201, 9-25 (2004) (Pubitemid 39318440)
93. H. Echchannaoui, K. Frei, C. Schnell, S. L. Leib, W. Zimmerli and R. Landmann: Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186, 798-806 (2002) (Pubitemid 35013432)
94. O. Schulz, S. S. Diebold, M. Chen, T. I. Naslund, M. A. Nolte, L. Alexopoulou, Y. T. Azuma, R. A. Flavell, P. Liljestrom and C. Reis E Sousa: Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892 (2005) (Pubitemid 40314900)
95. T. Wang, T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig and R. A. Flavell: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10, 1366-1373 (2004) (Pubitemid 40022719)
96. Y. Zhou, L. Ye, Q. Wan, L. Zhou, X. Wang, J. Li, S. Hu, D. Zhou and W. Ho: Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells. J Neurosci Res (2009)
97. T. R. Hawn, A. Verbon, K. D. Lettinga, L. P. Zhao, S. S. Li, R. J. Laws, S. J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, A. Ozinsky, K. D. Smith and A. Aderem: A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 198, 1563-1572 (2003) (Pubitemid 37467170)
98. C. Maaser, J. Heidemann, C. Von Eiff, A. Lugering, T. W. Spahn, D. G. Binion, W. Domschke, N. Lugering and T. Kucharzik: Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 172, 5056-5062 (2004) (Pubitemid 38456433)
99. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda and S. Akira: A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000) (Pubitemid 32015992)
100. S. Thoma-Uszynski, S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, S. Akira, M. V. Norgard, J. T. Belisle, P. J. Godowski, B. R. Bloom and R. L. Modlin: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291, 1544-1547 (2001) (Pubitemid 32179220)
101. U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck, S. Tancredi, C. Guiet, F. Briere, J. Vlach, S. Lebecque, G. Trinchieri and E. E. Bates: Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174, 2942-2950 (2005) (Pubitemid 40279713)